25 Stocks Moving In Monday's Pre-Market Session

By: via Benzinga
Gainers Aimmune Therapeutics Inc (NASDAQ: AIMT) rose 46.2 percent to $37.51 in pre-market trading in response to failed DBVT ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.